AVITA Medical (RCEL) Change in Acquisitions & Divestments (2022 - 2025)

AVITA Medical (RCEL) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $2.0 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments fell 80.0% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.5 million (down 61.38% YoY) and the FY2025 annual result came in at $27.5 million, down 61.38% from the prior year.
• Change in Acquisitions & Divestments slipped to $2.0 million in Q4 2025, from $3.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $24.3 million in Q1 2023 to a low of -$62.9 million in Q4 2023.
• A 4-year average of $7.0 million and a median of $11.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments tumbled 629.34% — and 2024, when it surged 900.0%.
• Tracing RCEL's Change in Acquisitions & Divestments over 4 years: stood at $11.9 million in 2022, then plunged by 629.34% to -$62.9 million in 2023, then surged by 115.89% to $10.0 million in 2024, then tumbled by 80.0% to $2.0 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $2.0 million (Q4 2025), $3.5 million (Q3 2025), and $11.0 million (Q2 2025), per Business Quant data.